BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 24692173)

  • 1. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
    Fan D; Takawale A; Basu R; Patel V; Lee J; Kandalam V; Wang X; Oudit GY; Kassiri Z
    Cardiovasc Res; 2014 Jul; 103(2):268-80. PubMed ID: 24692173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIMP3 is the primary TIMP to regulate agonist-induced vascular remodelling and hypertension.
    Basu R; Lee J; Morton JS; Takawale A; Fan D; Kandalam V; Wang X; Davidge ST; Kassiri Z
    Cardiovasc Res; 2013 Jun; 98(3):360-71. PubMed ID: 23524300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
    Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosis or hypertrophy: let TIMPs decide.
    Westermann D; Heymans S
    Cardiovasc Res; 2014 Jul; 103(2):196-7. PubMed ID: 24957072
    [No Abstract]   [Full Text] [Related]  

  • 6. TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
    Kandalam V; Basu R; Abraham T; Wang X; Soloway PD; Jaworski DM; Oudit GY; Kassiri Z
    Circ Res; 2010 Mar; 106(4):796-808. PubMed ID: 20056917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.
    Garcia AG; Wilson RM; Heo J; Murthy NR; Baid S; Ouchi N; Sam F
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H587-96. PubMed ID: 22730392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT2 Acts as a Cardioprotective Deacetylase in Pathological Cardiac Hypertrophy.
    Tang X; Chen XF; Wang NY; Wang XM; Liang ST; Zheng W; Lu YB; Zhao X; Hao DL; Zhang ZQ; Zou MH; Liu DP; Chen HZ
    Circulation; 2017 Nov; 136(21):2051-2067. PubMed ID: 28947430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.
    Matsui Y; Jia N; Okamoto H; Kon S; Onozuka H; Akino M; Liu L; Morimoto J; Rittling SR; Denhardt D; Kitabatake A; Uede T
    Hypertension; 2004 Jun; 43(6):1195-201. PubMed ID: 15123578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adiponectin deficiency, diastolic dysfunction, and diastolic heart failure.
    Sam F; Duhaney TA; Sato K; Wilson RM; Ohashi K; Sono-Romanelli S; Higuchi A; De Silva DS; Qin F; Walsh K; Ouchi N
    Endocrinology; 2010 Jan; 151(1):322-31. PubMed ID: 19850745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of senescence marker protein 30 exacerbates angiotensin II-induced cardiac remodelling.
    Misaka T; Suzuki S; Miyata M; Kobayashi A; Shishido T; Ishigami A; Saitoh S; Hirose M; Kubota I; Takeishi Y
    Cardiovasc Res; 2013 Aug; 99(3):461-70. PubMed ID: 23723062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
    Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
    Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension.
    Tsushima K; Osawa T; Yanai H; Nakajima A; Takaoka A; Manabe I; Ohba Y; Imai Y; Taniguchi T; Nagai R
    FASEB J; 2011 May; 25(5):1531-43. PubMed ID: 21266535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
    Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
    Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial overexpression of TIMP3 after myocardial infarction exerts beneficial effects by promoting angiogenesis and suppressing early proteolysis.
    Takawale A; Zhang P; Azad A; Wang W; Wang X; Murray AG; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2017 Aug; 313(2):H224-H236. PubMed ID: 28550172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
    Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
    Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TIMP3 deficiency exacerbates iron overload-mediated cardiomyopathy and liver disease.
    Zhabyeyev P; Das SK; Basu R; Shen M; Patel VB; Kassiri Z; Oudit GY
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H978-H990. PubMed ID: 29373036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice.
    Huggins CE; Domenighetti AA; Pedrazzini T; Pepe S; Delbridge LM
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):186-90. PubMed ID: 14608525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysyl oxidase overexpression accelerates cardiac remodeling and aggravates angiotensin II-induced hypertrophy.
    Galán M; Varona S; Guadall A; Orriols M; Navas M; Aguiló S; de Diego A; Navarro MA; García-Dorado D; Rodríguez-Sinovas A; Martínez-González J; Rodriguez C
    FASEB J; 2017 Sep; 31(9):3787-3799. PubMed ID: 28522596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.